Allertin
Composition
Allertin 20 Tablet: Each tablet contains Bilastine INN 20 mg.
Allertin ODT 10: Each orally disintegrating tablet contains Bilastine INN 10 mg.
Allertin Oral Solution: Each ml oral solution contains Bilastine INN 2.5 mg.
Indication
Seasonal Allergic Rhinitis: Bilastine is indicated for the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR) in patients of 4 years and older.
Chronic Spontaneous Urticaria: Bilastine is indicated for the relief of the symptoms associated with chronic spontaneous urticaria (CSU) (e.g. pruritus and hives), in patients of 4 years of age and older.
Dosage & Administration
Allertin 20 Tablet: Adults and adolescents 12 years of age and above: 20 mg tablet once daily. The tablet should be taken one hour before or two hours after intake of food.
Allertin Oral Solution: 4 ml of oral solution once daily for children 4 to 11 years of age. Recently, it has been approved in Latin America for children from 2 years of age. The oral solution should be taken one hour before or two hours after intake of food or fruit juice. Allertin ODT 10: The maximum recommended daily dose for children in
between 4 to 11 years is 10 mg Bilastine orally disintegrating tablet (1 tablet) and should not be exceed. If a dose is missed, the next scheduled dose should be taken. An extra dose is not necessary or as directed by the physician.
Aloglip
Composition
Aloglip 6.25 Tablet: Each film coated tablet contains Alogliptin Benzoate INN equivalent to Alogliptin 6.25 mg.
Aloglip 12.5 Tablet: Each film coated tablet contains Alogliptin Benzoate INN equivalent to Alogliptin 12.5 mg.
Aloglip 25 Tablet: Each film coated tablet contains Alogliptin Benzoate INN equivalent to Alogliptin 25 mg.
Indication
Aloglip is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type-2 diabetes mellitus.
Dose & Administration
The recommended dose in patients with normal renal function or mild renal impairment is 25 mg once daily or as directed by the physicians.
Azirox
Composition:
Azirox™ 500 Tablet: Each film coated tablet contains Azithromycin Dihydrate USP equivalent to Azithromycin 500 mg. Azirox™ Powder for Suspension (20 ml, 35 ml & 50 ml): Each 5 ml reconstituted suspension contains Azithromycin Dihydrate USP equivalent to Azithromycin 200 mg. Pharmacology Azirox™ (Azithromycin) is an azalide antibiotic active against Gram-positive and Gram-negative organisms. Azirox™ (Azithromycin) acts by binding to the 50S ribosomal subunit of susceptible organisms & thus interferes with microbial protein synthesis.
Indication:
Acute bacterial exacerbations of chronic obstructive pulmonary disease, Communityacquired pneumonia, Acute otitis media, Sinusitis, Pharyngitis, Tonsillitis, Skin and soft tissue infections, Urethritis and Cervicitis, Genital ulcer disease, Sexually transmitted diseases (STD), Typhoid fever.
Dose and Administration:
Adult dose: For Acute bacterial exacerbations of chronic obstructive pulmonary disease, community-acquired pneumonia, sinusitis, pharyngitis, tonsillitis and Skin and Soft tissue infections due to the indicated organisms: 500 mg once daily orally for 3 days or as an alternative given over 5 days with 500 mg dose on the first day followed by 250 mg once daily on days 2 through 5. Genital ulcer disease, non-gonococcal urethritis and cervicitis: 1 g (1000 mg) as a single dose. Urethritis and cervicitis due to Neisseria Gonorrhoeae: 2g (2000 mg) as a single dose. Sexually transmitted diseases: 1 g as a single dose.
Typhoid fever: 500 mg once daily for 7 days. Pediatric dose: For children over 6 months recommended dose is 10mg/kg once daily for 3 days 15-25 kg: 200 mg once daily for 3 days, 26-35 kg: 300 mg once daily for 3 days, 36-45 kg : 400 mg once daily for 3 days, Azirox™ should be taken at least 1 hour before or 2 hour after meal or as directed by the physician.
Artiforte
Composition:
Artiforte™ Sterile Eye Drops: Each ml contains Glycerin
USP 2 mg, Hypromellose BP 3.6 mg, Polyethylene glycol
400 USP 10 mg, Tetrahydrozoline Hydrochloride USP 0.5
mg, Zinc Sulfate Monohydrate USP equivalent to Zinc
Sulfate 2.5 mg. Preservative: Sodium Perborate BP 0.001%.
Indications:
Artiforte™ is indicated for the relief of discomfort and
redness of the eye due to minor eye irritations, for relief of
dryness of the eye, for the temporary relief of burning and
irritation due to exposure to wind or sun, for protection
against further irritation.
Dosage and Administration:
1 to 2 drops in the affected eye(s) up to 4 times daily or as
directed by the physician.
Children under 6 years of age: as per suggestion of
physician or as directed by the physician
Arokast
Composition:
Arokast™4 FT: Each flash tablet contains Montelukast Sodium USP equivalent to Montelukast 4 mg.
Arokast™5 FT: Each flash tablet contains Montelukast Sodium USP equivalent to Montelukast 5 mg.
Arokast™4: Each chewable tablet contains Montelukast Sodium USP equivalent to Montelukast 4 mg.
Arokast™5: Each chewable tablet contains Montelukast Sodium USP equivalent to Montelukast 5 mg.
Arokast™10: Each film coated tablet contains Montelukast Sodium USP equivalent to Montelukast 10 mg.
Indication:
Montelukast is indicated for the prophylaxis of asthma and
management of chronic asthma; symptomatic relief of seasonal allergic rhinitis in patients with asthma.
Dose & Administration:
Prophylaxis of asthma:
Adult and Child over 15 years: 10 mg once daily in the evening.
Child 6-15 years: 5 mg once daily in the evening.
Child 6 months-6 years: 4 mg once daily in the evening.
Seasonal allergic rhinitis:
Adult and Child over 15 years, 10 mg once daily in the evening.
The safety and efficacy of Montelukast was demonstrated in clinical trials where it was administered in the evening without regard to the time of food ingestion
Alleloc DS
Composition:
Alleloc™ Sterile Eye Drops: Each ml contains Olopatadine
Hydrochloride USP equivalent to Olopatadine 1 mg.
Alleloc™ DS Sterile Eye Drops: Each ml contains Olopatadine
Hydrochloride USP equivalent to Olopatadine 2 mg.
Indications:
Allergic conjunctivitis.
Dosage and administration:
Alleloc™: Instill one drop in the affected eye (s) twice daily or as
directed by the physician.
Alleloc™ DS: Instill one drop in the affected eye (s) once daily
or as directed by the physician.
